Generation of Clinical-Grade Monocyte-Derived Dendritic Cells Using the CliniMACS System
We describe the generation of monocyte-derived dendritic cells (MoDC) from leuka
We describe the generation of monocyte-derived dendritic cells (MoDC) from leukapheresis products using the CliniMACS system from Miltenyi Biotec. In a clinical setting, the method turned out to be feasible for the generation of clinical-grade MoDC from patients with metastatic renal-cell carcinoma. MoDC generated with this system exhibited a fully mature phenotype as well as high migratory and T-cell stimulatory capacity.